VAERS reports by lot

GSK Varicella/Shingles lot KB99G: VAERS reports

39 VAERS reports list lot KB99G as a GSK Varicella/Shingles vaccine, received between 2018-09-11 and 2019-10-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
39
Reports
8%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3726%
Injection-site / Local reaction2316%
Musculoskeletal2014%
Dermatological (non-injection-site)1712%
Neurological1611%
Cardiac / Cardiovascular118%
Gastrointestinal86%
Allergic / Anaphylactic75%
Respiratory53%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida4
California4
Texas4
Oklahoma3
Michigan2
New York2
Ohio2
Washington2
Hawaii2
North Carolina2
South Carolina1
Oregon1

Reports by month received

2018-0911
2018-1014
2018-113
2018-123
2019-011
2019-021
2019-031
2019-041
2019-072
2019-091
2019-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.